Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly’s connected insulin solutions
COLUMBIA, MD, and INDIANAPOLIS, IN, February 25, 2021 – Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected …
Welldoc Submits 510(k) for Bolus and Premixed Insulin Titration Program as Part of BlueStar®
Filing marks ninth 510(k) for digital diabetes solution BlueStar Columbia, MD – December 14, 2020 – Welldoc®, a trailblazer in digital health that is revolutionizing chronic disease management to help transform lives, …
Welldoc Expands Chronic Condition Platform to Include Behavioral Health
Derived from clinical evidence and experience building Welldoc’s digital solutions, new offering complements existing programs for diabetes, hypertension, heart failure and diabetes prevention Columbia, MD – December 7, 2020 – Welldoc®, a …
Welldoc® Thought Leaders to Present at Upcoming Industry Conferences and Meetings this Fall
Columbia, Maryland, October 12, 2020 – Welldoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in events at …
Welldoc and the University of Maryland’s Center for Health Information and Decision Systems (CHIDS) Employ AI to Identify Digital Health Habits™ that May Predict Improved Outcomes
Digital health habits can help personalize and optimize digital health experiences Columbia, MD – September 15, 2020 – Welldoc®, a trailblazer in digital health that is revolutionizing chronic disease management to help …
Welldoc Adds to Executive Team with new Commercial Leadership Hires
Keith Reynolds as Chief Operating Officer, David Driscoll as Chief Revenue Officer, and Linda Piazza as Senior Vice President of Sales will lead company’s continued expansion Columbia, MD – September 9, 2020 …